Exeter, UK – 2 May 2024 – QantX, a pioneering venture capital firm specialising in early-stage investments, is proud to announce the launch of the QantX 2024 Fund. This new fund is dedicated to supporting innovative, intellectual property-rich startups in vital sectors such as healthcare, life sciences, and sustainability.
Since its inception in 2021, QantX has established itself an active private funder of early-stage startups in the South West, with a local team based in Truro, Exeter, and Bristol. The firm has successfully backed 17 companies through equity investments and grants, demonstrating a robust track record to date with its inaugural fund.
“Our first fund laid a solid foundation, and with the QantX 2024 Fund, we aim to continue this success by investing in the next generation of disruptive technologies and businesses,” said Sir Richard Olver, Co-Founder of QantX. “We are well positioned to harness the high-quality pipeline of investment opportunities in the region, supported by our strategic partnerships and deep local presence.”
The QantX 2024 Fund will aim to fully deploy the raised capital during the 2024/2025 tax year, targeting 4-8 promising pre-seed and seed-stage companies. Investors in the fund can expect access to a curated selection of high-potential investment opportunities and may benefit from significant tax advantages under the SEIS and EIS schemes.
Richard Haycock, Co-Founder of QantX, added, “Beyond funding, we are committed to providing our portfolio companies with comprehensive support, mentorship, and access to global networks. Our close working relationships with the region’s universities and research institutions and the SETsquared Partnership, a leading startup hub, continues to be instrumental in our mission.”
The fund is currently open for investments, with interim closing dates set for 30 June 2024 and 30 September 2024.
For more information, please visit www.qantx.co.uk or contact enquiries@qantx.co.uk.
Disclaimer:
This press release is a financial promotion for the purposes of Section 21 of FSMA. It is issued by QantX Ltd FRN: 954072, an Appointed Representative of Kin Capital Partners LLP FRN:656789, an AIFM as defined by the AIFMD, who have approved it on 2nd May 2024. This document is not an offer to buy or sell securities and does not constitute a Direct Offer Financial Promotion. Applications for investment may only be made on the basis of the relevant application form, copies of which are available on request. No reliance is to be placed on the information contained in this document in making such an application. This material is directed only at persons in the UK. QantX invest in unquoted securities, which are classified by the FCA as a Non-Readily Realisable Securities (NRRS). As such, these products may only be marketed to limited categories of investors relating to knowledge, experience, or financial situation. Sole responsibility for suitability of the investment for an investor, including the legal, regulatory, tax and investment consequences and risks, lies with their financial adviser or with the investor should they choose not to seek advice. If an investor decides to pursue any investment opportunity, they will be investing in unquoted companies.
Investors should not invest unless they are prepared to lose all the money they invest. This is a high-risk investment. Past performance is not a reliable indicator of future results. Investment is of a long-term and illiquid nature. It can be difficult to value or sell unquoted investments. Any described tax advantages associated with investing are based on current legislation, are subject to change, and depend on the individual circumstances of each investor.